Metabolon Inc., a Durham, N.C.-based provider of biomarker discovery and analysis, has raised $13.1 million in Series D financing. New investor Keating Capital Inc. joins existing investors including Sevin Rosen Funds, Aurora Funds, Harris & Harris Group, Syngenta Ventures, Fletcher Spaght and Fulcrum Financial Partners.

Durham, N.C.-based Digitalsmiths has closed on $12.5 million in Series C financing. Technicolor led the round; all existing investors including .406 Ventures, Aurora Funds, Chrysalis Ventures, Capitol Broadcasting and Cisco also participated. Digitalsmiths develops video search and discovery products. Prior to the Series C round, Digitalsmiths had raised roughly $22 million in venture financing.

Venture capital-backed biotech company CardioFocus has secured $5 million in debt financing from Silicon Valley Bank. The company has raised venture funding from investors including Accuitive Medical Ventures, Aurora Funds, Kestrel Venture Management, Oxford Biosciences Partners, SV Life Sciences Advisors, HIG Ventures and KBL Healthcare Ventures. The debt financing will help it initiate its pivotal trial in the U.S. and to expand the commercialization of its products in Europe, the company said in a statement. CardioFocus is based in Massachusetts.

We’ll keep bringing you potential (and, some completed) funding opportunities from S.E.C. filings, and, please, if you’re an executive/banker/entrepreneur who knows of a potential deal for a VC, kick it our way. Today, we’ve got companies that just completed some fundraisings, as well as others that are just a hair shy, still. IN THE MARKET [...]

Grant Jackson has joined Council Ventures as a general partner. He previously was a partner with The Aurora Funds, where he focused on healthcare services and healthcare IT opportunities.